This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bristol-Myers Squibb Company (BMY)

: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 1.63B 2.03B 2.58B 2.50B
Operating Gains/Losses 839.00M 404.00M 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -942.00M -252.00M -504.00M 648.00M
(Increase) Decrease in Inventories 97.00M -254.00M -45.00M -103.00M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -919.00M -44.00M 412.00M -232.00M
(Decrease) Increase In Other Current Liabilities 47.00M 171.00M 126.00M -50.00M
(Increase) Decrease In Other Working Capital 689.00M 580.00M 499.00M -602.00M
Other Non-Cash Items 361.00M 589.00M 205.00M 5.33B
Net Cash From Continuing Operations 1.83B 3.15B 3.54B 6.94B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.83B 3.15B 3.54B 6.94B
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 2.79B 4.09B 1.81B 4.89B
Purchases of Property, Plant & Equipment -820.00M -526.00M -537.00M -548.00M
Acquisitions -403.00M 3.37B 9.00M -7.46B
Purchases of Short-Term Investments -3.14B -5.72B -1.86B -3.61B
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.57B 1.22B -572.00M -6.73B
Issuance of Debt 1.27B 0.00 1.49B 1.95B
Cash Used for Financing Activities
Issuance of Capital Stock 266.00M 288.00M 564.00M 463.00M
Repayment of Long-Term Debt -1.96B -676.00M -597.00M -2.11B
Repurchase of Capital Stock 0.00 0.00 -433.00M -2.40B
Payment of Cash Dividends -2.48B -2.40B -2.31B -2.29B
Other Financing Charges, Net -451.00M 349.00M 218.00M 51.00M
Net Cash From Financing Activities -3.35B -2.44B -1.07B -4.33B
Effect of Exchange Rate Changes -95.00M 58.00M 25.00M -1.00M
Net Change in Cash & Cash Equivalents -3.19B 1.99B 1.93B -4.12B
BMY News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

BMY Bristol-Myers Squibb Company

Chart of BMY

Analysts Ratings for BMY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 6 6
Moderate Buy 1 1 1 1
Hold 6 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 2 1 0 0
GET BMY ANALYST REPORT

BMY Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs